Acutus Medical Inc
OTC:AFIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Acutus Medical Inc
OTC:AFIB
|
US |
|
Vera Therapeutics Inc
NASDAQ:VERA
|
US |
|
H
|
Hove A/S
CSE:HOVE
|
DK |
|
Kahoot ASA
OSE:KAHOT
|
NO |
|
U
|
Union Bank of the Philippines
XPHS:UBP
|
PH |
|
Michigan Brewery Inc
OTC:BBUCQ
|
US |
|
H
|
HyosungONB Co Ltd
KOSDAQ:097870
|
KR |
|
M
|
Mogo Inc
F:SGCC
|
CA |
|
Novonix Ltd
ASX:NVX
|
AU |
|
Energy of Minas Gerais Co
BOVESPA:CMIG4
|
BR |
|
A
|
A-1 Acid Ltd
BSE:542012
|
IN |
|
Suofeiya Home Collection Co Ltd
SZSE:002572
|
CN |
|
C
|
Cognizant Technology Solutions Corp
F:COZ
|
US |
Acutus Medical Inc
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 338 full-time employees. The company went IPO on 2020-08-06. The firm designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The Company’s lead product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias with unmatched speed and precision. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly and accurately identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms.
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 338 full-time employees. The company went IPO on 2020-08-06. The firm designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The Company’s lead product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias with unmatched speed and precision. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly and accurately identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
